Familiáris hiperkoleszterinémia: vizsgálatok itt: Hollandia
10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 17.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleA Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
- Where
- Amsterdam
- Életkor
- 6 év to 17 év
- People
- 153 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07058077 · EU 2024-519068-42-00 - 3. fázisNot yet taking people in HollandiaStudy to evaluate efficacy and safety of inclisiran in children aged 2 to under 12 years of age with homozygous familial hypercholesterolemia
- Where
- Amsterdam
- Életkor
- Up to 17 év
- People
- 8 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-514595-41-00 - 3. fázisNot yet taking people in HollandiaStudy of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia
- Where
- Amsterdam
- Életkor
- 12 év to 17 év
- People
- 10 worldwide
- Run by
- Arrowhead Pharmaceuticals
See details and how to joinNCT07473843 · EU 2025-523662-24-00 - 1. fázisTaking peoplePhase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
- Where
- Amsterdam, Rotterdam
- Életkor
- 18 év to 70 év
- People
- 132 worldwide
- Run by
- Verve Therapeutics, Inc.
See details and how to joinNCT06451770 · EU 2025-522617-39-00 - 3. fázisFut, nem toborozLong-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
- Where
- Amsterdam, Rotterdam
- Életkor
- 2 év to 100 év
- People
- 195 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05682378 - 4. fázisTaking peopleOptimizing therapy with n=1-studies: negating the 'nocebo' effect in statin-intolerance
- Where
- Amersfoort, Arnhem, Dordrecht, Ede Gld, Nijmegen, Rotterdam, Tilburg, Utrecht, Zwolle
- Életkor
- 18 év and over
- People
- 249
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-507489-20-00 - No phaseTaking peopleAssessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)
- Where
- Amsterdam, Rotterdam
- Életkor
- 12 év and over
- People
- 52 worldwide
- Run by
- Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
See details and how to joinNCT07447648 - 3. fázisTaking peopleStudy to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Where
- Amsterdam
- Életkor
- 2 év to 11 év
- People
- 9 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597006 - 3. fázisTaking peopleStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Where
- Amsterdam
- Életkor
- 6 év to 11 év
- People
- 60 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597019 - No phaseTaking peopleHoFH, the International Clinical Collaborators Registry
- Where
- Amsterdam
- People
- 1000 worldwide
- Run by
- University of Pennsylvania
See details and how to joinNCT04815005